References
  1. Adams RD, Victor M, Mancall EL: Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. MA Arch Neurol Psychiatr. 1959; 81:154-72.
  2. Singh TD, Fugate JE, Rabinstein AA: Central pontine and extrapontine myelinolysis: a systematic review. Eur J Neurol . 2014; 21:1443-50.
  3. Simpson DM, Hallett M, Ashman EJ, et al: Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2016, 86, 1818–1826.
  4. Rosales RL, Chua-Yap, AS: Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity. J. Neural Transm. 2008, 115, 617–623.
  5. Andringa A, van de Port I, van Wegen E, et al: Effectiveness of botulinum toxin treatment for upper limb spasticity after stroke over different ICF domains: A systematic review and meta-analysis.Arch. Phys. Med. Rehabil. 2019, 100, 1703–1725.
  6. Francisco GE, Li S. Spasticity. In Braddom’s Physical Medicine and Rehabilitation , 5th ed.; Elsevier: Philadelphia, PA, USA, 2015.
  7. Sethi N, Singh S, DeBoulle K, et al: A Review of Complications Due to the Use of Botulinum Toxin A for Cosmetic Indications. Aesth Plast Surg 2020; Published online, https://doi.org/10.1007/s00266-020-01983-w
  8. Ramirez-Castaneda J, Jankovic J: Long-term efficacy and safety of botulinum toxin injections in dystonia. Toxins(Basel)2013;5(2):249–66.
  9. Baizabal-Carvallo JF, Jankovic J, Pappert E: Flu-like symptoms following botulinum toxin therapy. Toxicon 2011;58(1):1–7.
  10. Moore AP: Movement, visceral and autonomic disorders: use of botulinum toxin. Hospital Med 2003;64:452–9.
  11. Oliver, JD, Boesch RP, Mack KJ: Decreased Pulmonary Function During Botulinum Toxin A Therapy for Chronic Migraines in a 17‐Year‐Old Female. Headache: The Journal of Head and Face Pain2018;58 (8), 1259-1261.
  12. Schoene R, Brashear A, Turkel CC, et al: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Multicenter Study Evaluating the Effect of Botulinum Toxin Type A Treatment on Pulmonary Function in Patients With Poststroke Focal Spasticity. Archives of Physical Medicine and Rehabilitation 2006; 87(11), e10.
  13. Taysse L, Daulon S, Calvet JH, et al: Induction of acute lung injury after intranasal administration of toxin botulinum a complex.Toxicologic pathology 2005;33 (3), 336-342.
  14. Ermert LE, Bruckner HE, Walmrath DI, et al: Role of endothelial cytoskeleton in high-permeability edema due to botulinum C2 toxin in perfused rabbit lungs. American Journal of Physiology-Lung Cellular and Molecular Physiology 1995, 268.5: L753-L761.
  15. Ermert L, Duncker HR, Bruckner H, et al: Ultrastructural changes of lung capillary endothelium in response to botulinum C2 toxin.Journal of Applied Physiology 1997, 82.2: 382-388.